Skip to content
★ Sign in to follow
3billion, Inc. logo

3billion, Inc. Stock: price and insider trades · South Korea

쓰리빌리언

KR·Mcap ₩196.7BHealth Care

No insider purchase over the last 90 days. The latest, by 이해인, was filed 26 May 2026.

3billion, Inc.: what insiders have been doing

3billion, Inc. is a Health Care company. Its directors and officers file their transactions with DART (FSS). The last twelve months, up to 1 November 2026, brought 11 filings signed by 9 insiders.

The flow runs one way only: 8 insiders bought (10 purchases) and nobody sold on the market. The totals exclude 10 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 5 board members.

The last insider purchase was made public on 26 May 2026, 167 days ago. Filings reach the DART (FSS) feed a median of 7 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.

Compared with its exchange (2,655 companies, median 7 filings), a count of 11 filings is above the norm. Since 2024, the database holds 26 purchases and 6 sales by insiders of the company.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.

Insider Decl.
34
Thresholds
n/a
Buy Volume
€91M
26 ops. · all time
Sell Volume
€19M
6 ops. · all time

Who traded when

BuySale
이숙진3 buys
이해인2 buys
한국산업은행2 sales
Morganstanley&cointlplc1 buy
강기현1 buy
국민연금공단1 buy

+7 other insiders

Since the insiders bought

  • Filed 26 May 2026 · 167 days ago · €46k
    -45.3%
    Entry ₩9,780 · Close 30 Oct 2026 ₩5,350
  • Filed 26 May 2026 · 167 days ago · €120k
    -45.3%
    Entry ₩9,780 · Close 30 Oct 2026 ₩5,350
  • Filed 26 May 2026 · 167 days ago · €74k
    -45.3%
    Entry ₩9,780 · Close 30 Oct 2026 ₩5,350

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Fundamental score
Ranked 21,380 of 26,913 companies
31.1
score / 100
Value
25
Quality
37
FCF yld-3.7%
Earn yld-3.4%
EV/EBITDA·
ROE-29%
Gross mgn100%
Net mgn-46%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩6,180
Analyst consensus
0.00/5
Income statement
Revenue₩11.7B
Gross profit₩11.7B100% margin
EBITDA-₩3.3B-28% margin
Net income-₩5.4B-61.0% margin
Valuation
PER (forward)-55.2x
Balance sheet & cash
Market cap₩196.7B
Total debt₩3.4B
Free Cash Flow-₩5.9B
Debt / Equity14%
Profitability & ownership
ROE-29.2%
ROA-12.3%
% insiders24.7%
% institutions5.4%
Last declaration on 26 May 2026
Declarations35 total
  • Other
    Other(filed)
    0DART
  • ▲
    이사Executives(filed)
    €46kest.0DART
    8,000 sharesShareKRXDART:20260526000491
    Canonical exit: 24 Aug 2026 (T+90)
  • ▲
    Executives
    €120kest.0DART
    21,000 sharesKRXDART:20260526000453
    Canonical exit: 17 Aug 2026 (T+90)
  • ▲
    이사Executives(filed)
    €74kest.0DART
    13,000 sharesShareKRXDART:20260526000495
    Canonical exit: 24 Aug 2026 (T+90)
  • ▲
    이사Executives(filed)
    €46kest.0DART
    8,000 sharesShareKRXDART:20260526000484
    Canonical exit: 24 Aug 2026 (T+90)
  • ▲
    이사Executives(filed)
    €34kest.0DART
    6,000 sharesShareKRXDART:20260526000469
    Canonical exit: 24 Aug 2026 (T+90)
  • ▲
    Executives
    €187kest.0DART
    25,000 sharesKRXDART:20260401002584
    Canonical exit: 20 May 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Executives
    €14.2Mest.0DART
    1,509,827 sharesKRXDART:20260109000362
    Canonical exit: 5 Apr 2026 (T+90)
  • ▲
    이사Executives(filed)
    €54kest.0DART
    5,200 sharesShareKRXDART:20251209000094
    Canonical exit: 9 Mar 2026 (T+90)
  • ▲
    이사Executives(filed)
    €42kest.0DART
    4,000 sharesShareKRXDART:20251209000096
    Canonical exit: 9 Mar 2026 (T+90)
  • ▲
    이사Executives(filed)
    €91kest.0DART
    8,777 sharesShareKRXDART:20251209000097
    Canonical exit: 9 Mar 2026 (T+90)
  • ▼
    Related company / holdingExecutives
    €1.1Mest.0DART
    231,324 sharesKRXDART:20250702000517
  • ▼
    Related company / holdingExecutives
    €2.6Mest.0DART
    620,673 sharesKRXDART:20250206000454
  • ▼
    Related company / holdingExecutives
    €6.3Mest.0DART
    1,788,577 sharesKRXDART:20250103000530
  • ▼
    Related company / holdingExecutives
    €582kest.0DART
    134,109 sharesKRXDART:20241219000357
  • ▲
    이사Executives(filed)
    €40kest.0DART
    10,000 sharesShareKRXDART:20241216000335
    Canonical exit: 16 Mar 2025 (T+90)
  • ▲
    이사Executives(filed)
    €197kest.0DART
    49,628 sharesShareKRXDART:20241216000341
    Canonical exit: 16 Mar 2025 (T+90)
  • ●
    Executives
    0DART
    0KRXDART:20241216000324
  • ▲
    이사Executives(filed)
    €683kest.0DART
    171,700 sharesShareKRXDART:20241216000331
    Canonical exit: 16 Mar 2025 (T+90)
  • ▼
    Related company / holdingExecutives(filed)
    €3.9Mest.0DART
    1,000,000 sharesShareKRXDART:20241126000592
  • ▼
    Related company / holdingExecutives
    €4.9Mest.0DART
    1,267,000 sharesKRXDART:20241126000567
  • ▲
    이사Executives(filed)
    €586kest.0DART
    225,000 sharesShareKRXDART:20241120000423
    Canonical exit: 18 Feb 2025 (T+90)
  • ▲
    이사Executives(filed)
    €55kest.0DART
    21,000 sharesShareKRXDART:20241120000421
    Canonical exit: 18 Feb 2025 (T+90)
  • ▲
    이사Executives(filed)
    €468kest.0DART
    180,000 sharesShareKRXDART:20241120000416
    Canonical exit: 18 Feb 2025 (T+90)

25 of 35 declarations

About 3billion, Inc.

쓰리빌리언 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions to enhance patient health.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations